Pharmacovigilance Market Analysis, Market Size, Share, Regional Outlook, Growth Trends, Competitive Strategies and Forecasts, 2015 to 2022

Submitted by: Submitted by

Views: 10

Words: 1094

Pages: 5

Category: Business and Industry

Date Submitted: 10/05/2015 12:27 AM

Report This Essay

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Pharmacovigilance Market Analysis, Market Size, Share,

Regional Outlook, Growth Trends, Competitive Strategies

And Forecasts, 2015 To 2022

Industry Insights

Increasing rate of adverse drug reaction coupled with rising drug consumption globally is anticipated to

propel the market growth for pharmacovigilance market. It is basically pharmacological science which

helps in collecting, assessing, detecting, monitoring and preventing drug reaction after consumption of

pharmaceutical drugs. Increasing number of absolute and chronic diseases, rise in the level of drug

toxicity, and growing geriatric population base all over the world are the main drivers of this market.

Introduction of new technologies for pharmacies and huge investment in research and development are

anticipated to fuel the market for pharmacovigilance market. Strong government rules and regulation

regarding drug production & safety intensify the growth of this market.

Browse Detail Report With TOC @ http://www.hexaresearch.com/researchreport/pharmacovigilance-industry/

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Rising outsourcing and offshoring of pharmaceutical products is expected to have significant opportunity

in the developing countries. Globalization has shown positive effects in pharmaceutical industries due to

firms are now able to produce the same drug which are comparatively of lower costs.

Clinical Trial Insight

The global pharmacovigilance market is classified into clinical trial phases, type of methods and type of

service provider. Clinical trial segment is further divided into phase I, phase II, phase III and phase IV.

Phase IV has witnessed maximum usage rate in 2013. Phase IV passes through three hurdles before

getting any acceptance from regulatory authorities and clear all critical stages like quality inspection,

effectiveness testing and safe for the prescribed purpose. The data collected in...